Noradrenaline versus Dopamine in the Treatment of Circulatory Shock

Abstract

There is no difference in the rate of death between individuals randomised to receive dopamine or noradrenaline as first-line treatment of circulatory shock. However, the use of dopamine was associated with a greater incidence of adverse events, especially in those patients with cardiogenic shock.